Reduction in fracture rates with Denosumab compared to Alendronate in treatment naïve patients: a propensity-matched ‘real world’ cohort and instrumental variable analysis.
To compare the risk of hip and all osteoporotic fracture/s observed amongst treatment naïve users of subcutaneous denosumab and oral alendronate.
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Conference item |
| 出版: |
Springer
2017
|